Preclinical exploration of Kidney Diseases
Full range of in vitro and in vivo preclinical services to unravel the benefits of your molecules with certainty.
Why Choose NEPHRIX Biosolutions ?
Exclusive expertise in Kidney and Fibrotic diseases
Predictive, reproducible, and translational in vivo models
Fast study initiation and adaptable study designs
High-quality Histology and quantitative digital pathology
Ethical and 3Rs commitment
Trusted by renowned Pharma, Biotech and Academic partners
Featured Models

In vitro Assays using human primary fibroblasts from different origins (renal, lung, cardiac and skin)

Determining the potential toxicity of a drug candidate or preventing the tissue damage by therapeutic interventions.

Acute and chronic models using validated surgical procedures on mice and rats.
Read more...

Robust in vitro Senescence Assay platform using human primary cells from various tissue origins.

STZ rat & mouse model offers a reliable platform to explore the intricate mechanisms underlying this pathological condition including renal fibrosis, inflammation and glomerular alterations.

Bioanalysis platform to assess therapeutic’s efficacy, safety, and mechanism of action during the drug development process.
Strategic Partners





Contact
NEPHRIX Biosolutions
516, rue Pierre et Marie Curie31670 Labège - FRANCE
Tel +33 6 81 44 55 35
Mail: contact[at]nephrix-biosolutions.com